Abacus CEO seeks unique market access with new acquisition
The purchase of medicine wholesaler and partner Pluripharm will provide Abacus will a larger foothold in the Dutch market, which is unique in terms of parallel import of medicine.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL FRANK CHRISTENSEN
After one and a half years in a partnership with Dutch medicine wholesaler Pluripharm, Abacus Medicine has now decided to absorb the company into its organization.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
